Integra Lifesciences Holdings (IART) Gains from Sales and Divestitures (2012 - 2013)
Integra Lifesciences Holdings recorded quarterly Gains from Sales and Divestitures of -$1.9 million in Q1 2013, down 269.31% quarter-over-quarter from -$505000.0 in Q4 2012.
Integra Lifesciences Holdings' Gains from Sales and Divestitures history runs 2 years deep, the most recent figure standing at -$1.9 million for Q1 2013.
- In Q1 2013, Gains from Sales and Divestitures changed N/A year-over-year to -$1.9 million; the TTM figure through Mar 2013 stood at -$3.2 million (changed N/A YoY), while the FY2012 annual figure was -$1.3 million, down 14677.78% from the prior year.
- Gains from Sales and Divestitures came in at -$1.9 million for Q1 2013 at Integra Lifesciences Holdings, down from -$505000.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of -$376000.0 in Q3 2012 to a low of -$1.9 million in Q1 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | -1.87 Mn |
| Mar 31, 2013 | -1.87 Mn |
| Dec 31, 2012 | -505,000.00 |
| Dec 31, 2012 | -505,000.00 |
| Sep 30, 2012 | -376,000.00 |
| Sep 30, 2012 | -376,000.00 |
| Jun 30, 2012 | -431,000.00 |
| Jun 30, 2012 | -431,000.00 |